GENVOR INCORPORATED Sale of Stock, Consideration Received on Transaction
GENVOR INCORPORATED (GNVR) reported Sale of Stock, Consideration Received on Transaction of $911.60 thousand for the 12-month period ending 2024-09-30, per its 10-K filed 2025-12-10.
Financial Statements › Notes › Equity
us-gaap:SaleOfStockConsiderationReceivedOnTransaction · last filed 2025-12-10
- GENVOR INCORPORATED sale of stock, consideration received on transaction for the quarter ending 2024-06-30 was $85.00K, a 13.33% increase year-over-year.
- GENVOR INCORPORATED sale of stock, consideration received on transaction for the quarter ending 2024-03-31 was $248.00K, a 1884.00% increase year-over-year.
- GENVOR INCORPORATED sale of stock, consideration received on transaction for the quarter ending 2023-12-31 was $578.60K, a 285.73% increase year-over-year.
- GENVOR INCORPORATED sale of stock, consideration received on transaction for the quarter ending 2023-06-30 was $75.00K.
- GENVOR INCORPORATED sale of stock, consideration received on transaction for fiscal 2024 was $911.60K, a 151.46% increase from fiscal 2023.
- GENVOR INCORPORATED sale of stock, consideration received on transaction for fiscal 2023 was $362.52K.
| Period end | Sale of Stock, Consideration Received on Transaction 3 month | Sale of Stock, Consideration Received on Transaction 6 month | Sale of Stock, Consideration Received on Transaction 9 month | Sale of Stock, Consideration Received on Transaction 12 month |
|---|---|---|---|---|
| 2024-09-30 | $911.60K 10-K · filed 2025-12-10 | |||
| 2024-06-30 | $85.00K 10-Q · filed 2025-09-08 | $333.00K derived: sum of 2 quarters · filed 2025-09-08 | $911.60K derived: sum of 3 quarters · filed 2025-09-08 | |
| 2024-03-31 | $248.00K 10-Q · filed 2025-09-08 | $826.60K derived: sum of 2 quarters · filed 2025-09-08 | ||
| 2023-12-31 | $578.60K 10-Q · filed 2025-09-08 | |||
| 2023-09-30 | $362.52K 10-K/A · filed 2025-09-09 | |||
| 2023-06-30 | $75.00K 10-Q/A · filed 2024-01-16 | $87.50K derived: sum of 2 quarters · filed 2024-01-16 | $237.50K derived: sum of 3 quarters · filed 2024-01-16 | |
| 2023-03-31 | $12.50K 10-Q/A · filed 2024-01-16 | $162.50K derived: sum of 2 quarters · filed 2024-01-16 | ||
| 2022-12-31 | $150.00K 10-Q/A · filed 2024-01-16 |